Daily treatments of Cialis and Zydena draw favorable market response

Published: 2012-05-16 06:57:00

Updated: 2012-05-16 06:57:00

The daily therapies of Lilly’s Cialis and Dong-A Zydena have enjoyed robust sales ahead of imminent launching of 14 Viagra generics as the main patent for Viagra, the world’s bestselling anti-impotence pill, expires on May 17.

Last year, Lilly Korea sold 42.8 billion worth of Cialis including ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK